Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11459357
Polymyxin compounds
granted -
US 11459374
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11459300
Deuterated compounds and uses thereof
granted -
US 11459360
Recombinant HIV-1 envelope proteins and their use
granted -
US 11459323
Monocyclic β-lactam compound for treating bacterial infection
granted -
US 11459305
Processes for the preparation of uracil derivatives
granted -
US 11458212
Molecular imaging of cancer cells in vivo
granted -
US 11458143
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 11459325
Heterocyclic compound
granted -
US 11459335
N/O-linked Degrons and Degronimers for protein degradation
granted -
US 11458126
DHODH inhibitor for use in treating hematologic cancers
granted -
US 11458174
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11459320
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders
granted -
US 11458210
Compounds and compositions for targeting brain injuries and methods of use thereof
granted -
US 11459308
Broad spectrum inhibitors of filoviruses
granted -
US 11459298
Class of dicationic compounds as well as the preparative method and the use thereof
granted -
US 11459372
Gene-edited natural killer cells
granted -
AU 2021230529
Use of compounds in the treatment of fungal infections
granted -
US 11453891
Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9
granted -
US 11453725
Methods for DNA-dependent targeting of a cell permeant antibody
granted -
US 11453870
Ligase fusion proteins and application thereof
granted -
US 11453785
Method for producing surface-treated colored inorganic particles
granted -
US 11453710
Activatable interleukin 12 polypeptides and methods of use thereof
granted -
US 11452724
Methods for treating amyotrophic lateral sclerosis
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.